Neuroinflammation	neuroinflammation	O	O	OTHERS	I
and	and	O	O	O	O
behavioral	behavioral	O	O	OTHERS	I
abnormalities	abnormalities	O	O	OTHERS	I
after	after	O	O	O	O
neonatal	neonatal	O	O	O	O
terbutaline	terbutaline	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
in	in	O	O	O	O
rats	rats	O	O	O	O
:	:	O	O	O	O
implications	implications	O	O	O	O
for	for	O	O	O	O
autism	autism	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Autism	autism	O	DISEASE	OTHERS	I
is	is	O	O	O	O
a	a	O	O	O	O
neurodevelopmental	neurodevelopmental	O	O	OTHERS	I
disorder	disorder	O	O	OTHERS	I
presenting	presenting	O	O	O	O
before	before	O	O	O	O
3	3	O	O	O	O
years	years	O	O	O	O
of	of	O	O	O	O
age	age	O	O	O	O
with	with	O	O	O	O
deficits	deficits	O	O	OTHERS	I
in	in	O	O	OTHERS	I
communication	communication	O	O	OTHERS	I
and	and	O	O	OTHERS	I
social	social	O	O	OTHERS	I
skills	skills	O	O	OTHERS	I
and	and	O	O	O	O
repetitive	repetitive	O	O	OTHERS	I
behaviors	behaviors	O	O	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
addition	addition	O	O	O	O
to	to	O	O	O	O
genetic	genetic	O	O	O	O
influences	influences	O	O	O	O
,	,	O	O	O	O
recent	recent	O	O	O	O
studies	studies	O	O	O	O
suggest	suggest	O	O	O	O
that	that	O	O	O	O
prenatal	prenatal	O	O	O	O
drug	drug	O	O	O	O
or	or	O	O	O	O
chemical	chemical	O	O	O	O
exposures	exposures	O	O	O	O
are	are	O	O	O	O
risk	risk	O	O	O	O
factors	factors	O	O	O	O
for	for	O	O	O	O
autism	autism	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Terbutaline	terbutaline	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
a	a	O	O	O	O
beta2-adrenoceptor	beta2-adrenoceptor	O	O	O	O
agonist	agonist	O	O	O	O
used	used	O	O	O	O
to	to	O	O	O	O
arrest	arrest	O	O	O	O
preterm	preterm	O	O	OTHERS	I
labor	labor	O	O	OTHERS	I
,	,	O	O	O	O
has	has	O	O	O	O
been	been	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
increased	increased	O	O	O	O
concordance	concordance	O	O	O	O
for	for	O	O	O	O
autism	autism	O	DISEASE	OTHERS	I
in	in	O	O	O	O
dizygotic	dizygotic	O	O	O	O
twins	twins	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
studied	studied	O	O	O	O
the	the	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
terbutaline	terbutaline	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
microglial	microglial	O	O	O	O
activation	activation	O	O	O	O
in	in	O	O	O	O
different	different	O	O	O	O
brain	brain	O	O	O	O
regions	regions	O	O	O	O
and	and	O	O	O	O
behavioral	behavioral	O	O	O	O
outcomes	outcomes	O	O	O	O
in	in	O	O	O	O
developing	developing	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

Newborn	newborn	O	O	O	O
rats	rats	O	O	O	O
were	were	O	O	O	O
given	given	O	O	O	O
terbutaline	terbutaline	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
10	10	O	O	O	O
mg/kg	mg/kg	O	O	O	O
)	)	O	O	O	O
daily	daily	O	O	O	O
on	on	O	O	O	O
postnatal	postnatal	O	O	O	O
days	days	O	O	O	O
(	(	O	O	O	O
PN	pn	O	O	O	O
)	)	O	O	O	O
2	2	O	O	O	O
to	to	O	O	O	O
5	5	O	O	O	O
or	or	O	O	O	O
PN	pn	O	O	O	O
11	11	O	O	O	O
to	to	O	O	O	O
14	14	O	O	O	O
and	and	O	O	O	O
examined	examined	O	O	O	O
24	24	O	O	O	O
h	h	CHEMICALS	O	OTHERS	I
after	after	O	O	O	O
the	the	O	O	O	O
last	last	O	O	O	O
dose	dose	O	O	O	O
and	and	O	O	O	O
at	at	O	O	O	O
PN	pn	O	O	O	O
30	30	O	O	O	O
.	.	O	O	O	O

Immunohistochemical	immunohistochemical	O	O	O	O
studies	studies	O	O	O	O
showed	showed	O	O	O	O
that	that	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
terbutaline	terbutaline	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
PN	pn	O	O	O	O
2	2	O	O	O	O
to	to	O	O	O	O
5	5	O	O	O	O
produced	produced	O	O	O	O
a	a	O	O	O	O
robust	robust	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
microglial	microglial	O	O	O	O
activation	activation	O	O	O	O
on	on	O	O	O	O
PN	pn	O	O	O	O
30	30	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
cerebral	cerebral	O	O	O	O
cortex	cortex	O	O	O	O
,	,	O	O	O	O
as	as	O	O	O	O
well	well	O	O	O	O
as	as	O	O	O	O
in	in	O	O	O	O
cerebellar	cerebellar	O	O	O	O
and	and	O	O	O	O
cerebrocortical	cerebrocortical	O	O	O	O
white	white	O	O	O	O
matter	matter	O	O	O	O
.	.	O	O	O	O

None	none	O	O	O	O
of	of	O	O	O	O
these	these	O	O	O	O
effects	effects	O	O	O	O
occurred	occurred	O	O	O	O
in	in	O	O	O	O
animals	animals	O	O	O	O
given	given	O	O	O	O
terbutaline	terbutaline	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
PN	pn	O	O	O	O
11	11	O	O	O	O
to	to	O	O	O	O
14	14	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
behavioral	behavioral	O	O	O	O
tests	tests	O	O	O	O
,	,	O	O	O	O
animals	animals	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
terbutaline	terbutaline	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
PN	pn	O	O	O	O
2	2	O	O	O	O
to	to	O	O	O	O
5	5	O	O	O	O
showed	showed	O	O	O	O
consistent	consistent	O	O	O	O
patterns	patterns	O	O	O	O
of	of	O	O	O	O
hyper-reactivity	hyper-reactivity	O	O	O	O
to	to	O	O	O	O
novelty	novelty	O	O	O	O
and	and	O	O	O	O
aversive	aversive	O	O	O	O
stimuli	stimuli	O	O	O	O
when	when	O	O	O	O
assessed	assessed	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
novel	novel	O	O	O	O
open	open	O	O	O	O
field	field	O	O	O	O
,	,	O	O	O	O
as	as	O	O	O	O
well	well	O	O	O	O
as	as	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
acoustic	acoustic	O	O	O	O
startle	startle	O	O	OTHERS	I
response	response	O	O	O	O
test	test	O	O	O	O
.	.	O	O	O	O

Our	our	O	O	O	O
findings	findings	O	O	O	O
indicate	indicate	O	O	O	O
that	that	O	O	O	O
beta2-adrenoceptor	beta2-adrenoceptor	O	O	O	O
overstimulation	overstimulation	O	O	O	O
during	during	O	O	O	O
an	an	O	O	O	O
early	early	O	O	O	O
critical	critical	O	O	O	O
period	period	O	O	O	O
results	results	O	O	O	O
in	in	O	O	O	O
microglial	microglial	O	O	O	O
activation	activation	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
innate	innate	O	O	O	O
neuroinflammatory	neuroinflammatory	O	O	OTHERS	I
pathways	pathways	O	O	O	O
and	and	O	O	O	O
behavioral	behavioral	O	O	OTHERS	I
abnormalities	abnormalities	O	O	OTHERS	I
,	,	O	O	O	O
similar	similar	O	O	O	O
to	to	O	O	O	O
those	those	O	O	O	O
described	described	O	O	O	O
in	in	O	O	O	O
autism	autism	O	DISEASE	OTHERS	I
.	.	O	O	O	O

This	this	O	O	O	O
study	study	O	O	O	O
provides	provides	O	O	O	O
a	a	O	O	O	O
useful	useful	O	O	O	O
animal	animal	O	O	O	O
model	model	O	O	O	O
for	for	O	O	O	O
understanding	understanding	O	O	O	O
the	the	O	O	O	O
neuropathological	neuropathological	O	O	O	O
processes	processes	O	O	O	O
underlying	underlying	O	O	O	O
autism	autism	O	DISEASE	OTHERS	I
spectrum	spectrum	O	O	OTHERS	I
disorders	disorders	O	O	OTHERS	I
.	.	O	O	O	O

